Boston Scientific Investment Agreement with Exclusive Option to Acquire Farapulse, Inc.

Boston Scientific Announces Agreement to Acquire Cortex, Inc.

November 4, 2024

Medical Devices

Boston Scientific Corporation entered into a definitive agreement to acquire Cortex, Inc., an Ajax Health company, to complement its electrophysiology portfolio with Cortex’s diagnostic mapping technology for complex atrial fibrillation. Cortex’s OptiMap System uses a basket catheter and proprietary algorithm to identify atrial fibrillation triggers outside the pulmonary veins, which is intended to support more targeted ablation strategies.

Boston Scientific Acquires Baylis Medical Company Inc.

October 6, 2021

Medical Devices

Boston Scientific Corporation entered into a definitive agreement to acquire Baylis Medical Company Inc. for an upfront payment of $1.75 billion, subject to closing adjustments. The acquisition is expected to expand Boston Scientific’s electrophysiology and structural heart portfolios by adding the RF NRG and VersaCross transseptal platforms and related guidewires, sheaths, and dilators.

Electromedical Products International Acquires Pulvinar Neuro

March 17, 2022

Medical Devices

Electromedical Products International (EPI) has acquired Pulvinar Neuro, a research-oriented medical device company focused on closed-loop neuromodulation and digital therapeutics. The deal expands EPI's scientific and research capabilities to accelerate development and commercialization of Pulvinar's transcranial alternating current stimulation (tACS), individualized feedback stimulation, and cloud-enabled digital therapeutics.

Boston Scientific to Acquire Nalu Medical, Inc.

October 17, 2025

Healthcare Services

Boston Scientific entered into a definitive agreement to acquire Nalu Medical, Inc., a privately held medical technology company focused on minimally invasive chronic pain neuromodulation. The deal includes an upfront cash payment of approximately $533 million for the remaining equity not already owned by Boston Scientific, with Boston Scientific expecting closing in the first half of 2026.

Boston Scientific to Acquire Penumbra in $14.5 Billion Deal

January 16, 2026

Healthcare Services

Boston Scientific signed a definitive agreement to acquire Penumbra, Inc. for about $14.5 billion (enterprise value) in a cash-and-stock transaction. The deal is intended to expand Boston Scientific’s cardiovascular franchise and create a scaled position in mechanical thrombectomy and adjacent neurovascular markets, and is expected to close in 2026 subject to shareholder and regulatory approvals.

I-Pulse Acquires CSI Technologies to Expand U.S. High-Energy Capacitor Manufacturing

March 20, 2026

Industrial Services

I-Pulse, a pulsed power technology company, announced it acquired CSI Technologies, a Vista, California-based manufacturer of high-energy, high-voltage capacitors for industrial, medical, and defense applications. The acquisition is intended to expand I-Pulse’s U.S. manufacturing capabilities, strengthen the supply chain, and speed development and deployment of pulsed power technologies through integrated capacitor design and production expertise.